Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound

Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Anuradha, Urati, Bhavana, Valamla, Chary, Padakanti Sandeep, Rajana, Naveen, Parida, Kishan Kumar, Kalia, Nitin Pal, Khatri, Dharmendra Kumar, Mehra, Neelesh Kumar
Format: Dataset
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Anuradha, Urati
Bhavana, Valamla
Chary, Padakanti Sandeep
Rajana, Naveen
Parida, Kishan Kumar
Kalia, Nitin Pal
Khatri, Dharmendra Kumar
Mehra, Neelesh Kumar
description Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by incorporating NE into 1% carbopol®934. Furthermore, particle size, polydispersity index, thermodynamic stability studies, rheology, spreadability, drug content, in-vitro drug release, ex-vivo permeation, anti-oxidant assay, antimicrobial studies, angioirritance, HAT-CAM assay, in-vitro and in-vivo studies were determined. Results: NE has a particle size of 17.79 ± 0.61 nm, 0.206 ± 0.012 PDI & found to be thermodynamically stable. DIAGEL exhibited pseudoplastic behavior, sustained drug release, better permeation of TQ and a drug content of 98.54 ± 0.08%. DIAGEL stored for 6 months at room temperature and 2–8°C showed no degradation. Further, an improved angiogenesis, absence of angio-irritancy, remarkable antioxidant and antimicrobial activities against Candida albicans & S. aureus were observed. Cytotoxicity analysis revealed nearly 2.28 -folds higher IC50 value than drug solution. Furthermore, inflammatory mediators were reduced in DIAGEL treated animal groups. The histopathological studies confirmed skin healing with regeneration and granulation of tissue. Conclusion: The novel formulation has strong anti-inflammatory, angiogenesis, antioxidant and appreciable diabetic wound healing properties. Diabetic foot ulcer is a skin-inflammatory disease condition characterized by high blood glucose levels, & poor wound healing affecting mostly diabetic patients. Thymoquinone is a natural compound with anti-oxidant, anti-microbial, & anti-inflammatory, low solubility makes it challenging for formulation development. Nanoemulgel containing combination of oils with high solubility of thymoquinone can be an ideal one. We employed pseudo ternary phase diagram for selection of Smix ratio for developing annaoemlusion and to optimize the nanoemulsion we used here Randomized I-optimal mixture design, for characterization of nanoemulsion and nanoemulgel we used TEM, for gel properties we used here rheometer and texture analyzer. Developed nanoemulgel shows remarkable in-vitro antimicrobial activity against Candida albicans and S. aureus & also stimulating angiogenesis & negligible angioirritation by CAM assay. In-vitro cell lines studies were conducted on L929 cell to check the cyt
doi_str_mv 10.6084/m9.figshare.27878226
format Dataset
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_27878226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_27878226</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_278782263</originalsourceid><addsrcrecordid>eNqdzk0OgjAUBOBuXBj1Bi56ARGQ8LM2Gg7Avqn0AS9p-7C0MXh6MZELuJpMMpN8jB2TOMrjMjubKuqwnwbpIEqLsijTNN-yuhlmQ8-AlixwTVKB4lZaAhN0D5qj5ZN3MHp6k6d2qWhVaJeVQvkAjy1_UbBqzzad1BMcfrlj2f3WXOuTkl626EGMDo10s0hi8QUJU4kVJFbQ5c_bBwK3Suw</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound</title><source>DataCite</source><creator>Anuradha, Urati ; Bhavana, Valamla ; Chary, Padakanti Sandeep ; Rajana, Naveen ; Parida, Kishan Kumar ; Kalia, Nitin Pal ; Khatri, Dharmendra Kumar ; Mehra, Neelesh Kumar</creator><creatorcontrib>Anuradha, Urati ; Bhavana, Valamla ; Chary, Padakanti Sandeep ; Rajana, Naveen ; Parida, Kishan Kumar ; Kalia, Nitin Pal ; Khatri, Dharmendra Kumar ; Mehra, Neelesh Kumar</creatorcontrib><description><![CDATA[Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by incorporating NE into 1% carbopol®934. Furthermore, particle size, polydispersity index, thermodynamic stability studies, rheology, spreadability, drug content, in-vitro drug release, ex-vivo permeation, anti-oxidant assay, antimicrobial studies, angioirritance, HAT-CAM assay, in-vitro and in-vivo studies were determined. Results: NE has a particle size of 17.79 ± 0.61 nm, 0.206 ± 0.012 PDI & found to be thermodynamically stable. DIAGEL exhibited pseudoplastic behavior, sustained drug release, better permeation of TQ and a drug content of 98.54 ± 0.08%. DIAGEL stored for 6 months at room temperature and 2–8°C showed no degradation. Further, an improved angiogenesis, absence of angio-irritancy, remarkable antioxidant and antimicrobial activities against Candida albicans & S. aureus were observed. Cytotoxicity analysis revealed nearly 2.28 -folds higher IC50 value than drug solution. Furthermore, inflammatory mediators were reduced in DIAGEL treated animal groups. The histopathological studies confirmed skin healing with regeneration and granulation of tissue. Conclusion: The novel formulation has strong anti-inflammatory, angiogenesis, antioxidant and appreciable diabetic wound healing properties. Diabetic foot ulcer is a skin-inflammatory disease condition characterized by high blood glucose levels, & poor wound healing affecting mostly diabetic patients. Thymoquinone is a natural compound with anti-oxidant, anti-microbial, & anti-inflammatory, low solubility makes it challenging for formulation development. Nanoemulgel containing combination of oils with high solubility of thymoquinone can be an ideal one. We employed pseudo ternary phase diagram for selection of Smix ratio for developing annaoemlusion and to optimize the nanoemulsion we used here Randomized I-optimal mixture design, for characterization of nanoemulsion and nanoemulgel we used TEM, for gel properties we used here rheometer and texture analyzer. Developed nanoemulgel shows remarkable in-vitro antimicrobial activity against Candida albicans and S. aureus & also stimulating angiogenesis & negligible angioirritation by CAM assay. In-vitro cell lines studies were conducted on L929 cell to check the cytotoxicity of developed nanoformulation and also to check the cellular internalization, ROS, morphology, migration assay and apoptosis. In diabetic wound animal model nanoemulgel showed significant decreased levels of TNF-α, IL-6, MMP-9 and IL-1β. Histopathological studies also showed that absence of inflammatory cells, and granulation of tissue was seen. The amalgamation of these data strongly suggests that the nanoemulgel is a possible strategy for drug-delivery systems, with significant promising for the management of diabetic wound.]]></description><identifier>DOI: 10.6084/m9.figshare.27878226</identifier><language>eng</language><publisher>Taylor &amp; Francis</publisher><subject>Biochemistry ; Biotechnology ; Cancer ; Chemical Sciences not elsewhere classified ; Developmental Biology ; FOS: Clinical medicine ; FOS: Health sciences ; Immunology ; Infectious Diseases ; Medicine</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,1894</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.27878226$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Anuradha, Urati</creatorcontrib><creatorcontrib>Bhavana, Valamla</creatorcontrib><creatorcontrib>Chary, Padakanti Sandeep</creatorcontrib><creatorcontrib>Rajana, Naveen</creatorcontrib><creatorcontrib>Parida, Kishan Kumar</creatorcontrib><creatorcontrib>Kalia, Nitin Pal</creatorcontrib><creatorcontrib>Khatri, Dharmendra Kumar</creatorcontrib><creatorcontrib>Mehra, Neelesh Kumar</creatorcontrib><title>Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound</title><description><![CDATA[Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by incorporating NE into 1% carbopol®934. Furthermore, particle size, polydispersity index, thermodynamic stability studies, rheology, spreadability, drug content, in-vitro drug release, ex-vivo permeation, anti-oxidant assay, antimicrobial studies, angioirritance, HAT-CAM assay, in-vitro and in-vivo studies were determined. Results: NE has a particle size of 17.79 ± 0.61 nm, 0.206 ± 0.012 PDI & found to be thermodynamically stable. DIAGEL exhibited pseudoplastic behavior, sustained drug release, better permeation of TQ and a drug content of 98.54 ± 0.08%. DIAGEL stored for 6 months at room temperature and 2–8°C showed no degradation. Further, an improved angiogenesis, absence of angio-irritancy, remarkable antioxidant and antimicrobial activities against Candida albicans & S. aureus were observed. Cytotoxicity analysis revealed nearly 2.28 -folds higher IC50 value than drug solution. Furthermore, inflammatory mediators were reduced in DIAGEL treated animal groups. The histopathological studies confirmed skin healing with regeneration and granulation of tissue. Conclusion: The novel formulation has strong anti-inflammatory, angiogenesis, antioxidant and appreciable diabetic wound healing properties. Diabetic foot ulcer is a skin-inflammatory disease condition characterized by high blood glucose levels, & poor wound healing affecting mostly diabetic patients. Thymoquinone is a natural compound with anti-oxidant, anti-microbial, & anti-inflammatory, low solubility makes it challenging for formulation development. Nanoemulgel containing combination of oils with high solubility of thymoquinone can be an ideal one. We employed pseudo ternary phase diagram for selection of Smix ratio for developing annaoemlusion and to optimize the nanoemulsion we used here Randomized I-optimal mixture design, for characterization of nanoemulsion and nanoemulgel we used TEM, for gel properties we used here rheometer and texture analyzer. Developed nanoemulgel shows remarkable in-vitro antimicrobial activity against Candida albicans and S. aureus & also stimulating angiogenesis & negligible angioirritation by CAM assay. In-vitro cell lines studies were conducted on L929 cell to check the cytotoxicity of developed nanoformulation and also to check the cellular internalization, ROS, morphology, migration assay and apoptosis. In diabetic wound animal model nanoemulgel showed significant decreased levels of TNF-α, IL-6, MMP-9 and IL-1β. Histopathological studies also showed that absence of inflammatory cells, and granulation of tissue was seen. The amalgamation of these data strongly suggests that the nanoemulgel is a possible strategy for drug-delivery systems, with significant promising for the management of diabetic wound.]]></description><subject>Biochemistry</subject><subject>Biotechnology</subject><subject>Cancer</subject><subject>Chemical Sciences not elsewhere classified</subject><subject>Developmental Biology</subject><subject>FOS: Clinical medicine</subject><subject>FOS: Health sciences</subject><subject>Immunology</subject><subject>Infectious Diseases</subject><subject>Medicine</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2024</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNqdzk0OgjAUBOBuXBj1Bi56ARGQ8LM2Gg7Avqn0AS9p-7C0MXh6MZELuJpMMpN8jB2TOMrjMjubKuqwnwbpIEqLsijTNN-yuhlmQ8-AlixwTVKB4lZaAhN0D5qj5ZN3MHp6k6d2qWhVaJeVQvkAjy1_UbBqzzad1BMcfrlj2f3WXOuTkl626EGMDo10s0hi8QUJU4kVJFbQ5c_bBwK3Suw</recordid><startdate>20241121</startdate><enddate>20241121</enddate><creator>Anuradha, Urati</creator><creator>Bhavana, Valamla</creator><creator>Chary, Padakanti Sandeep</creator><creator>Rajana, Naveen</creator><creator>Parida, Kishan Kumar</creator><creator>Kalia, Nitin Pal</creator><creator>Khatri, Dharmendra Kumar</creator><creator>Mehra, Neelesh Kumar</creator><general>Taylor &amp; Francis</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20241121</creationdate><title>Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound</title><author>Anuradha, Urati ; Bhavana, Valamla ; Chary, Padakanti Sandeep ; Rajana, Naveen ; Parida, Kishan Kumar ; Kalia, Nitin Pal ; Khatri, Dharmendra Kumar ; Mehra, Neelesh Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_278782263</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biochemistry</topic><topic>Biotechnology</topic><topic>Cancer</topic><topic>Chemical Sciences not elsewhere classified</topic><topic>Developmental Biology</topic><topic>FOS: Clinical medicine</topic><topic>FOS: Health sciences</topic><topic>Immunology</topic><topic>Infectious Diseases</topic><topic>Medicine</topic><toplevel>online_resources</toplevel><creatorcontrib>Anuradha, Urati</creatorcontrib><creatorcontrib>Bhavana, Valamla</creatorcontrib><creatorcontrib>Chary, Padakanti Sandeep</creatorcontrib><creatorcontrib>Rajana, Naveen</creatorcontrib><creatorcontrib>Parida, Kishan Kumar</creatorcontrib><creatorcontrib>Kalia, Nitin Pal</creatorcontrib><creatorcontrib>Khatri, Dharmendra Kumar</creatorcontrib><creatorcontrib>Mehra, Neelesh Kumar</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Anuradha, Urati</au><au>Bhavana, Valamla</au><au>Chary, Padakanti Sandeep</au><au>Rajana, Naveen</au><au>Parida, Kishan Kumar</au><au>Kalia, Nitin Pal</au><au>Khatri, Dharmendra Kumar</au><au>Mehra, Neelesh Kumar</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound</title><date>2024-11-21</date><risdate>2024</risdate><abstract><![CDATA[Aim: To treat diabetic wound healing with a novel Thymoquinone (TQ) loaded nanoformulation by using combination of essentials oils. Methods: TQ nanoemulsion (NE) was developed with seabuckthorn & lavender essential oils by phase inversion method and mixture design. Further, DIAGEL is obtained by incorporating NE into 1% carbopol®934. Furthermore, particle size, polydispersity index, thermodynamic stability studies, rheology, spreadability, drug content, in-vitro drug release, ex-vivo permeation, anti-oxidant assay, antimicrobial studies, angioirritance, HAT-CAM assay, in-vitro and in-vivo studies were determined. Results: NE has a particle size of 17.79 ± 0.61 nm, 0.206 ± 0.012 PDI & found to be thermodynamically stable. DIAGEL exhibited pseudoplastic behavior, sustained drug release, better permeation of TQ and a drug content of 98.54 ± 0.08%. DIAGEL stored for 6 months at room temperature and 2–8°C showed no degradation. Further, an improved angiogenesis, absence of angio-irritancy, remarkable antioxidant and antimicrobial activities against Candida albicans & S. aureus were observed. Cytotoxicity analysis revealed nearly 2.28 -folds higher IC50 value than drug solution. Furthermore, inflammatory mediators were reduced in DIAGEL treated animal groups. The histopathological studies confirmed skin healing with regeneration and granulation of tissue. Conclusion: The novel formulation has strong anti-inflammatory, angiogenesis, antioxidant and appreciable diabetic wound healing properties. Diabetic foot ulcer is a skin-inflammatory disease condition characterized by high blood glucose levels, & poor wound healing affecting mostly diabetic patients. Thymoquinone is a natural compound with anti-oxidant, anti-microbial, & anti-inflammatory, low solubility makes it challenging for formulation development. Nanoemulgel containing combination of oils with high solubility of thymoquinone can be an ideal one. We employed pseudo ternary phase diagram for selection of Smix ratio for developing annaoemlusion and to optimize the nanoemulsion we used here Randomized I-optimal mixture design, for characterization of nanoemulsion and nanoemulgel we used TEM, for gel properties we used here rheometer and texture analyzer. Developed nanoemulgel shows remarkable in-vitro antimicrobial activity against Candida albicans and S. aureus & also stimulating angiogenesis & negligible angioirritation by CAM assay. In-vitro cell lines studies were conducted on L929 cell to check the cytotoxicity of developed nanoformulation and also to check the cellular internalization, ROS, morphology, migration assay and apoptosis. In diabetic wound animal model nanoemulgel showed significant decreased levels of TNF-α, IL-6, MMP-9 and IL-1β. Histopathological studies also showed that absence of inflammatory cells, and granulation of tissue was seen. The amalgamation of these data strongly suggests that the nanoemulgel is a possible strategy for drug-delivery systems, with significant promising for the management of diabetic wound.]]></abstract><pub>Taylor &amp; Francis</pub><doi>10.6084/m9.figshare.27878226</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.27878226
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_27878226
source DataCite
subjects Biochemistry
Biotechnology
Cancer
Chemical Sciences not elsewhere classified
Developmental Biology
FOS: Clinical medicine
FOS: Health sciences
Immunology
Infectious Diseases
Medicine
title Thymoquinone loaded nanoemulgel in streptozotocin induced diabetic wound
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T09%3A02%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Anuradha,%20Urati&rft.date=2024-11-21&rft_id=info:doi/10.6084/m9.figshare.27878226&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_27878226%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true